Patient Satisfaction During Artificial Induction of Labor by Cervical Ripening

NCT05096104 | Completed

• 1 other identifier: 8294
• Study Type: observational
• Target: 800
• Locations: 1 country
• Sites: 1

Brief Summary

20% of deliveries take place following an artificial induction of labor. The latter sometimes requires prior cervical ripening, of which the two most widely used methods in France are oral misoprostol and the balloon catheter, left to the discretion of clinicians. The objective of this study is to observe which cervical maturation method patients choose when an artificial induction of labor with an unfavorable cervical status must be carried out, and to observe the patient's criteria as to the choice made, as well as their experience and their satisfaction with artificial induction of labor, in order to improve our clinical practices, the experience of childbirth, and promote patient autonomy.

Conditions

Cervical Ripening

Keywords

Cervical Ripening; PREGNANCY; LABOR INDUCED; Artificial induction

Outcome Measures

Primary Outcomes (1)

• Retrospective study of the cervical ripening method that patients choose when artificial induction of labor with unfavorable cervical status must be performed

  Files analysed retrospectively from JFebruary 01, 2020 to February 29, 2021 will be examined]

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult woman who underwent induction of labor between February 1, 2020 and February 29, 2021

You may qualify if:

• Adult woman (≥18 years old)
• Patient who underwent induction of labor between February 1, 2020 and February 29, 2021
• Patient not having expressed her opposition, after information, to the reuse of her data for the purposes of this research.

You may not qualify if:

• Patient who expressed her opposition to participating in the study
• Absence of prior cervical maturation (Bishop score greater than or equal to 6 on the day of initiation)
• Gestational age less than 37 weeks, multiple pregnancy, scarred uterus, non-cephalic presentation, death in utero and severe fetal malformation (requiring neonatal resuscitation or with a palliative care plan)
• Patient for whom the triggering method was chosen by the practitioner
• Patient under guardianship, curatorship or safeguard of justice

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de gynécologie Obstétrique - Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

Study Officials

• Nicolas SANANES, MD, PhD

  Service de gynécologie Obstétrique - Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 6, 2021
• First Posted: October 27, 2021
• Study Start: August 6, 2021
• Primary Completion: June 8, 2022
• Study Completion: August 8, 2022
• Last Updated: December 12, 2023

Record last verified: 2023-12

Locations

FR (1)